We have published an article in 2013 based on a report of the journal Fertility and Sterility (98; 1470-1473, 2012) describing a case of portal vein thrombosis, a serious medical problem, after in-vitro fertilization in a 39-year-old woman. We said the authors concluded that “thromboembolic events are a rare complication of assisted reproductive technology (ART). In women who present with upper abdominal pain during ART, portal vein thrombosis should be considered in the differential diagnosis”.
In the current coronavirus crisis, new studies have been made to prevent unnecessary risks in ART. A recent article published in the US National Library of Medicine National Institutes of Health untiled “Assisted reproduction and thromboembolic risk in the COVID-19 pandemic” warns of possible thromboembolic complications in the new scenery of COVID 19 pandemic.
“[…]the thrombotic risk described during virus infection and that reported in the context of assisted reproduction treatments[…]
IVF treatments in coronavirus crisis: a risk of thromboembolic complications
The authors approach the issue in the new context, “The COVID-19 pandemic has significantly increased mortality in many countries, with the number of infected cases increasing exponentially worldwide. One of the main determining factors of the poor prognosis in these patients is the development of coagulopathy. Moreover, it is well known that assisted reproductive technology procedures confer a risk of thromboembolic complications. This commentary analyses specific aspects coexisting between the thrombotic risk described during virus infection and that reported in the context of assisted reproduction treatments. Based on known pathophysiological aspects of virus infection and ovarian stimulation, there are common elements that deserve to be taken into account. In the present context, any risk of hyperstimulation should be avoided (read more HERE).”